These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25797543)

  • 21. Eliminating HCV: a marathon, not a sprint.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):515. PubMed ID: 32416859
    [No Abstract]   [Full Text] [Related]  

  • 22. Localized US Efforts to Eliminate Hepatitis C.
    Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
    Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leaving no one behind: Towards equitable global elimination of hepatitis C.
    Dahl EH; Zahid H; Aslam K; Jafri W
    J Glob Health; 2020 Jun; 10(1):010308. PubMed ID: 32257136
    [No Abstract]   [Full Text] [Related]  

  • 24. Australia commits funds to curb hepatitis C epidemic.
    McCall C
    Lancet; 2016 Jan; 387(10017):419. PubMed ID: 26869556
    [No Abstract]   [Full Text] [Related]  

  • 25. A path to eradication of hepatitis C in low- and middle-income countries.
    Graham CS; Swan T
    Antiviral Res; 2015 Jul; 119():89-96. PubMed ID: 25615583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral hepatitis: impressive advances but still a long way to eradication of the disease.
    Marcellin P; Asselah T
    Liver Int; 2014 Feb; 34 Suppl 1():1-3. PubMed ID: 24373070
    [No Abstract]   [Full Text] [Related]  

  • 27. Is hepatitis C virus eradication around the corner only 25 years after its discovery?
    Ippolito G; Capobianchi MR; Lanini S; Antonelli G
    Int J Antimicrob Agents; 2015 Feb; 45(2):111-2. PubMed ID: 25249016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lowering barriers to HCV elimination.
    Samuel S
    Aust J Gen Pract; 2021 Oct; 50(10):695. PubMed ID: 34590081
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathways to the elimination of hepatitis C: prioritising access for all.
    Pedrana AE; Sacks-Davis R; Doyle JS; Hellard ME
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1023-1026. PubMed ID: 28942660
    [No Abstract]   [Full Text] [Related]  

  • 30. 30 Years on the Road to Hepatitis C Elimination.
    Thomas DL
    J Infect Dis; 2020 Nov; 222(Suppl 9):S739-S740. PubMed ID: 33245352
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].
    Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
    Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178
    [No Abstract]   [Full Text] [Related]  

  • 32. The phases of hepatitis C elimination: achieving WHO elimination targets.
    Pedrana A; Munari S; Stoové M; Doyle J; Hellard M
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435
    [No Abstract]   [Full Text] [Related]  

  • 33. Implementation of the Lancet Standing Commission on Liver Disease in the UK.
    Williams R; Ashton K; Aspinall R; Bellis MA; Bosanquet J; Cramp ME; Day N; Dhawan A; Dillon J; Dyson J; Ferguson J; Foster G; Gilmore SI; Glynn M; Guthrie JA; Hudson M; Kelly D; Langford A; Newsome P; O'Grady J; Pryke R; Ryder S; Samyn M; Sheron N; Verne J
    Lancet; 2015 Nov; 386(10008):2098-2111. PubMed ID: 26700394
    [No Abstract]   [Full Text] [Related]  

  • 34. A world without hepatitis C.
    Ryder S; Dillon J
    Health Serv J; 2014 May; 124(6397):21-3. PubMed ID: 25033511
    [No Abstract]   [Full Text] [Related]  

  • 35. The Second Biggest Infectious Disease Killer in the U.S.: Hepatitis C Virus Infection and Steps Towards its Elimination in Rhode Island and Beyond.
    Taylor LE
    R I Med J (2013); 2020 Jun; 103(5):19-21. PubMed ID: 32481774
    [No Abstract]   [Full Text] [Related]  

  • 36. Remaining challenges in HCV elimination.
    Capraru C; Feld JJ
    J Hepatol; 2021 Apr; 74(4):964-965. PubMed ID: 33589319
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment and prevention of hepatitis C--progress and challenges. The Danish Society of Hepatology].
    Bukh J; Christensen E; Krogsgaard K
    Ugeskr Laeger; 2003 Mar; 165(12):1233. PubMed ID: 12701283
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C: a new horizon.
    Chang KM
    Gastroenterology; 2006 Dec; 131(6):1667-8. PubMed ID: 17188957
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of recurrent hepatitis C].
    Berenguer M
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():63-7. PubMed ID: 11968347
    [No Abstract]   [Full Text] [Related]  

  • 40. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Asselah T; Marcellin P
    Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.